Stock-Based Compensation for Humana (HUM)
Stock-Based Compensation for Humana (HUM): headline value $241.00M · YoY +16.4%. Annual and quarterly series, chart, and tables are below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .

HUM
Currently viewingStock-Based CompensationSwitch metric
Latest period
$241.00M
YoY change
+16.4%
5Y CAGR
+5.9%
Peak year (2025)
$241.00M
Latest annual
$241.00M
Stock-Based Compensation history chart for Humana (HUM) from 1990 to 2025
Stock-Based Compensation history table for Humana (HUM) from 1990 to 2025
| Fiscal year | Period ended | Reported | Stock-Based Compensation | YoY |
|---|---|---|---|---|
| 2025 | $241.00M | +16.4% | ||
| 2024 | $207.00M | +18.3% | ||
| 2023 | $175.00M | -19.0% | ||
| 2022 | $216.00M | +20.0% | ||
| 2021 | $180.00M | -0.6% | ||
| 2020 | $181.00M | +11.0% | ||
| 2019 | $163.00M | +19.0% | ||
| 2018 | $137.00M | -12.7% | ||
| 2017 | $157.00M | +36.5% | ||
| 2016 | $115.00M | +5.5% | ||
| 2015 | $109.00M | +11.2% | ||
| 2014 | $98.00M | +6.5% | ||
| 2013 | $92.00M | +12.2% | ||
| 2012 | $82.00M | +22.4% | ||
| 2011 | $67.00M | +6.4% | ||
| 2010 | $62.95M | -4.4% | ||
| 2009 | $65.87M | +19.0% | ||
| 2008 | $55.37M | +31.4% | ||
| 2007 | $42.13M | +29.4% | ||
| 2006 | $32.56M | +187.6% | ||
| 2005 | $11.32M | +181.6% | ||
| 2004 | $4.02M | -36.6% | ||
| 2003 | $6.34M | — | ||
| 2002 | $0 | — | ||
| 2001 | $0 | -100.0% | ||
| 2000 | $30.00M | — | ||
| 1999 | $0 | — | ||
| 1998 | $0 | — | ||
| 1997 | $0 | — | ||
| 1996 | $0 | — | ||
| 1995 | $0 | — | ||
| 1994 | $0 | — | ||
| 1993 | $0 | — | ||
| 1992 | $0 | — | ||
| 1991 | $0 | — | ||
| 1990 | $0 | — |
Stock-Based Compensation values are taken from Humana's reported cash flow statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
In 2025, Humana (HUM) stock-based compensation totalled $241.00M – grew 16.4% year-over-year.
Across 2020–2025 (5 years), Humana stock-based compensation produced a CAGR of +5.9% – with the latest reading among the more recent periods of the dataset.
Across the available history, stock-based compensation reached its high of $241.00M in 2025 and its low of $0 in 1990.
Within Healthcare, Humana (HUM) ranks 5th among 8 peers we track. The peer median for stock-based compensation is $313.00M.
Humana Stock-Based Compensation by Year
Humana Stock-Based Compensation 2025: $241.00M
Humana stock-based compensation in 2025 was $241.00M, grew 16.4% from 2024. This figure represents the highest annual value in the available history.
Humana Stock-Based Compensation 2024: $207.00M
Humana stock-based compensation in 2024 was $207.00M, grew 18.3% from 2023.
Humana Stock-Based Compensation 2023: $175.00M
Humana stock-based compensation in 2023 was $175.00M, declined 19.0% below 2022.
Humana Stock-Based Compensation 2022: $216.00M
Humana stock-based compensation in 2022 was $216.00M, grew 20.0% from 2021.
Humana Stock-Based Compensation 2021: $180.00M
Humana stock-based compensation in 2021 was $180.00M.
See more financial history for Humana (HUM).
Sector peers — Stock-Based Compensation
Companies in the same sector as Humana, ranked by their latest stock-based compensation.
| Company | Stock-Based Compensation | Sector |
|---|---|---|
| Johnson & Johnson (JNJ) | $1.35B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $971.00M | Healthcare |
| AbbVie Inc. (ABBV) | $955.00M | Healthcare |
| Eli Lilly and Company (LLY) | $626.00M | Healthcare |
| AstraZeneca PLC (AZN) | $0 | Healthcare |
| Merck & Co., Inc. (MRK) | $0 | Healthcare |
| Amgen Inc. (AMGN) | $0 | Healthcare |
| Novo Nordisk A/S (NVO) | $0 | Healthcare |
Frequently asked questions
What is Humana's stock-based compensation?
Latest reported stock-based compensation for Humana (HUM) is $241.00M (period ending December 31, 2025).
How has Humana stock-based compensation changed year-over-year?
Humana (HUM) stock-based compensation changed +16.4% year-over-year on the latest annual filing.
What is the long-term growth rate of Humana stock-based compensation?
Humana (HUM) stock-based compensation compound annual growth rate is +5.9% over the most recent 5 years available.
When did Humana stock-based compensation hit its highest annual value?
Humana stock-based compensation reached its highest annual value of $241.00M in 2025.
What was Humana stock-based compensation in 2024?
Humana (HUM) stock-based compensation in 2024 was $207.00M.
What was Humana stock-based compensation in 2025?
Humana (HUM) stock-based compensation in 2025 was $241.00M.
Metrics overview
Pick a metric for charts, filings and peers — each row shows the latest TTM or most-recent-quarter value.
Explore more
HUM Overview
Company profile, financial tools, and key metrics
HUM Revenue Counter
Earns $4,112 every second. See per minute, hour, and day.
HUM Earnings Counter
Earns $37.67 per second net profit. See per minute, hour, and day.
HUM Economic Scale
Exceeds Puerto Rico (US)'s GDP. Compare with world economies.
HUM What If Invested
What if you had invested $1,000? See historical returns from any date.
HUM How It Makes Money
Discover visual breakdown of $129.66B in revenue — where it comes from and where it goes.
HUM Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
HUM Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
HUM Daily Price Character
Balanced · 48.4% historical win rate (green days). Streaks & record days.
HUM Buybacks
0.49% TTM buyback yield. Shareholder yield & SBC comparison.
HUM Stock Split History
8 splits on record. Dates, ratios, and cumulative multiple.
HUM Dividend Profile
Yield: 1.46%. Safety: 3/8. See full history.
HUM Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
HUM Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.